European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) meeting with all eligible organisations

• Date:
  Wednesday, 26 November 2014, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This is a meeting with representatives of the PCWP and all eligible patient and consumer organisations. Topics for discussion are involvement of patients and consumers in the Agency's activities, involvement of patient representatives in Agency committees, reporting of adverse drug reactions, feedback on the risk-management-plan (RMP) summary pilot, feedback from the International Society for Pharmacoepidemiology (ISPE) conference, the ADVANCE project on vaccines and a survey on collaboration at national level. Registration by invitation only.

Documents

Agenda - European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) meeting with all eligible organisations - November 2014

Reference Number: EMA/632557/2014

List of participants of the European Medicines Agency Human Scientific Committees’ Working Party with Patients’ and Consumers’ organisations (PCWP) meeting with all eligible organisations

Reference Number: EMA/702226/2014

Minutes of the European Medicines Agency Human Scientific Committees’ Working Party with Patients’ and Consumers’ organisations (PCWP) meeting with all eligible organisations

Reference Number: EMA/1639/2015

Presentation - Overview of European Medicines Agency’s interaction with patients and consumers organisations - 2014 (Nathalie Bere)

Presentation - Revised framework of European Medicines Agency interaction with patients, consumers and their organisations (Isabelle Moulon)

Presentation - Implementation of new eligibility requirements (Nathalie Bere)

Presentation - Developments in European Medicines Agency’s communications: what’s coming up? (Monika Benstetter)

Summary:

European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) meeting with all eligible organisations

Presentation - European Medicines Agency collaboration with health technology assessment bodies (Jane Moseley)

Presentation - Results from the questionnaire to PDCO members (Sofia Nordenmalm, Benjamin Pelle)

Presentation - Committee for Advanced Therapies update (Kieran Breen)

Presentation - COMP update to the Patients' and Consumers' Working Party (Daniel O’Connor)

Presentation - Increasing access to adverse drug reaction reports on the web (Steven Le Meur) AA

Presentation - Publication of Risk Management Plan summaries: proposal for analysis of the experience of the 1-year pilot phase (Juan Garcia Burgos, Rosa Gonzalez-Quevedo)

Presentation - Patient focus at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2014 (Priya Bahri)

Presentation - The Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE) (Xavier Kurz)

Presentation - The Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE) project on vaccines (Jose Drabwell)

Presentation - European Medicines Agency Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals Working Party (HCPWP) meeting dates for 2015 (Nathalie B...